Rigel Pharmaceuticals Inc (RIGL) — Free Cash Flow Yield
Biotech & Pharma
| Metric | Value |
|---|---|
| FCF Yield | 9.0% |
| Biotech & Pharma Sector Avg FCF Yield | 13.9% |
| Annual Free Cash Flow | $79M |
| Market Cap | $881M |
| P/E Ratio | 2.9x |
Rigel Pharmaceuticals Inc's FCF yield of 9.0% is below the Biotech & Pharma sector average (13.9%).
Frequently Asked Questions
What is Rigel Pharmaceuticals Inc's (RIGL) free cash flow yield?
Rigel Pharmaceuticals Inc's (RIGL) free cash flow yield is 9.0%. That is below the Biotech & Pharma sector average (13.9%).
Is RIGL's free cash flow yield good?
At 9.0%, RIGL's free cash flow yield is considered good — yields above 10% are generally excellent, 7–10% good, 4–7% fair, and below 4% weak, though context varies by sector and growth stage.
How much free cash flow does Rigel Pharmaceuticals Inc generate?
Rigel Pharmaceuticals Inc generated $79M in free cash flow, against a market cap of $881M.
How is free cash flow yield calculated?
Free cash flow yield = (Free Cash Flow ÷ Market Capitalization) × 100%. Free cash flow equals operating cash flow minus capital expenditures.
Data from public filings. Not investment advice. Calculate your own FCF yield →